Results 241 to 250 of about 352,696 (330)
Microbiota diversity and differences in the respiratory tract of children with pneumonia
Differences in microbial communities in the upper and lower respiratory tract in patients with pneumonia were investigated in this study by sequencing the 16S rRNA genes in pharyngeal swabs and alveolar lavage fluid. Forty‐three subjects were enrolled in the study, and one upper and one lower respiratory tract sample were collected from each subject ...
Dandan Ge+4 more
wiley +1 more source
Evolving nutrition therapy in cystic fibrosis: Adapting to the CFTR modulator era. [PDF]
Vavrina K+5 more
europepmc +1 more source
Parotid Gland Function in Children with Cystic Fibrosis and Child Control Subjects [PDF]
Jeanette Blomfield+3 more
openalex +1 more source
ABSTRACT Respiratory syncytial virus (RSV) is one of the most common respiratory pathogens in children under 5 years of age worldwide and it seriously threatens children's health. In recent years, great progress has been made in the field of RSV‐related diseases.
Committee of Pediatrics+16 more
wiley +1 more source
Is There a Role for Lumacaftor/Ivacaftor in Young Children with Cystic Fibrosis? [PDF]
Martin I, Grasemann H.
europepmc +1 more source
Comparative Proteomics of Salinity Stress Responses in Fish and Aquatic Invertebrates
ABSTRACT Fluctuating salinity is symptomatic of climate change challenging aquatic species. The melting of polar ice, rising sea levels, coastal surface and groundwater salinization, and increased evaporation in arid habitats alter salinity worldwide. Moreover, the frequency and intensity of extreme weather events such as rainstorms and floods increase,
Maxime Leprêtre+3 more
wiley +1 more source
Prevalence and Characteristics of Patients with Cystic Fibrosis-Related Diabetes in Croatia. [PDF]
Kirigin Biloš LS+7 more
europepmc +1 more source
Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing
The review highlights nature‐inspired nanocarriers for CRISPR delivery, emphasizing viral vectors, extracellular vesicles, liposomes, and lipid nanoparticles. It discusses their roles in improving specificity, minimizing immunogenicity, and overcoming barriers in genome editing. Recent advancements, challenges, and therapeutic applications are explored,
Elizabeth Maria Clarissa+4 more
wiley +1 more source